KRT15 in Early Breast Cancer Screening and Correlation with HER2 Positivity, Pathological Grade and N Stage
Biomarkers in Medicine · 2023
DOI: 10.2217/bmm-2023-0130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomarkers in Medicine, 2023. Verfasst von Zijing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
This study was designed to explore KRT15 dysregulation and its correlation with clinical characteristics among ductal carcinoma in situ (DCIS), DCIS with microinvasion (DCIS-MI) and invasive breast cancer (IBC) patients.
Methods
KRT15 from lesion samples of 50 DCIS patients, 48 DCIS-MI patients and 50 IBC patients was detected by immunohistochemistry.
Results
KRT15 discriminated IBC patients from DCIS patients (area under the curve [AUC] = 0.895; 95% CI = 0.836-0.954) and DCIS-MI patients (AUC = 0.707; 95% CI = 0.606-0.808). In DCIS patients, KRT15 was negatively correlated with pathological grade (p = 0.015). In DCIS-MI patients, KRT15 was positively related to estrogen receptor positivity but negatively associated with Ki-67 (both p < 0.05). In IBC patients, KRT15 was negatively linked to HER2 positivity, histological grade, N stage and tumor node metastasis stage (all p < 0.05).
Conclusion
KRT15 assessment may help with early breast cancer screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
- Department of Pathology, Huashan Hospital, Fudan University, Shanghai, 200040, China.
ORCID-Profile: Qiang Zou
Zitieren
APA
Zhang, Z., Wang, H., Jin, Y., Zhou, J., Chu, C., Tang, F., Zou, L., & Zou, Q. (2023). KRT15 in Early Breast Cancer Screening and Correlation with HER2 Positivity, Pathological Grade and N Stage. Biomarkers in Medicine. https://doi.org/10.2217/bmm-2023-0130
Vancouver
Zhang Z, Wang H, Jin Y, Zhou J, Chu C, Tang F, et al. KRT15 in Early Breast Cancer Screening and Correlation with HER2 Positivity, Pathological Grade and N Stage. Biomarkers in Medicine. 2023. doi:10.2217/bmm-2023-0130
BibTeX
@article{Zhang2023,
author = {Zhang, Zijing and Wang, Hongying and Jin, Yiting and Zhou, Jian and Chu, Chengyu and Tang, Feng and Zou, Liping and Zou, Qiang},
title = {KRT15 in Early Breast Cancer Screening and Correlation with HER2 Positivity, Pathological Grade and N Stage},
journal = {Biomarkers in Medicine},
year = {2023},
doi = {10.2217/bmm-2023-0130}
}
EUVIMED